[go: up one dir, main page]

GB9920148D0 - Novel composition - Google Patents

Novel composition

Info

Publication number
GB9920148D0
GB9920148D0 GBGB9920148.5A GB9920148A GB9920148D0 GB 9920148 D0 GB9920148 D0 GB 9920148D0 GB 9920148 A GB9920148 A GB 9920148A GB 9920148 D0 GB9920148 D0 GB 9920148D0
Authority
GB
United Kingdom
Prior art keywords
novel composition
novel
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920148.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9920148.5A priority Critical patent/GB9920148D0/en
Publication of GB9920148D0 publication Critical patent/GB9920148D0/en
Priority to JP2001518027A priority patent/JP2003507409A/ja
Priority to EP00956670A priority patent/EP1207855A1/fr
Priority to PCT/GB2000/003312 priority patent/WO2001013889A1/fr
Priority to AU68542/00A priority patent/AU6854200A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9920148.5A 1999-08-25 1999-08-25 Novel composition Ceased GB9920148D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9920148.5A GB9920148D0 (en) 1999-08-25 1999-08-25 Novel composition
JP2001518027A JP2003507409A (ja) 1999-08-25 2000-08-25 ナブメトンを含んでなる医薬組成物
EP00956670A EP1207855A1 (fr) 1999-08-25 2000-08-25 Composition pharmaceutique comprenant du nabumetone
PCT/GB2000/003312 WO2001013889A1 (fr) 1999-08-25 2000-08-25 Composition pharmaceutique comprenant du nabumetone
AU68542/00A AU6854200A (en) 1999-08-25 2000-08-25 Pharmaceutical composition comprising nabumetone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9920148.5A GB9920148D0 (en) 1999-08-25 1999-08-25 Novel composition

Publications (1)

Publication Number Publication Date
GB9920148D0 true GB9920148D0 (en) 1999-10-27

Family

ID=10859799

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9920148.5A Ceased GB9920148D0 (en) 1999-08-25 1999-08-25 Novel composition

Country Status (5)

Country Link
EP (1) EP1207855A1 (fr)
JP (1) JP2003507409A (fr)
AU (1) AU6854200A (fr)
GB (1) GB9920148D0 (fr)
WO (1) WO2001013889A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60105023T2 (de) * 2000-06-28 2005-08-18 Smithkline Beecham P.L.C., Brentford Nassvermahlungsverfahren
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
GB0516549D0 (en) 2005-08-12 2005-09-21 Sulaiman Brian Milling system
KR100715355B1 (ko) * 2005-09-30 2007-05-07 주식회사유한양행 프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법
GB0613925D0 (en) 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201857D0 (en) * 1992-01-29 1992-03-18 Smithkline Beecham Plc Novel compound
US5518738A (en) * 1995-02-09 1996-05-21 Nanosystem L.L.C. Nanoparticulate nsaid compositions
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
GB9828204D0 (en) * 1998-12-21 1999-02-17 Smithkline Beecham Plc Process
GB9905512D0 (en) * 1999-03-10 1999-05-05 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
EP1207855A1 (fr) 2002-05-29
JP2003507409A (ja) 2003-02-25
WO2001013889A1 (fr) 2001-03-01
AU6854200A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
SG110072A1 (en) Novel composition
GB9921147D0 (en) Novel composition
GB9902520D0 (en) Composition
GB9919683D0 (en) Composition
AP2001002273A0 (en) Rescorcinol composition
GB2366984B (en) Composition
GB9920148D0 (en) Novel composition
GB9914446D0 (en) Composition
GB2357714B (en) Composition
GB9914582D0 (en) Composition
GB9911933D0 (en) Composition
GB9907909D0 (en) Novel composition
GB9930569D0 (en) Novel composition
GB9926931D0 (en) Novel composition
GB9922544D0 (en) Novel composition
GB9914487D0 (en) Novel composition
GB9928693D0 (en) Novel composition
GB9907270D0 (en) Composition
GB9906690D0 (en) Composition
GB9916249D0 (en) Composition
GB9916248D0 (en) Composition
GB9916231D0 (en) Composition
GB9916226D0 (en) Composition
GB9916225D0 (en) Composition
GB9916197D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)